Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial

BACKGROUND: Female sex is an independent risk factor for stroke and systemic embolic events in patients with atrial fibrillation. This study aimed to examine the efficacy and safety profile of edoxaban in women versus men. METHODS: The ENGAGE AF-TIMI 48 trial (Effective Anticoagulation with Factor X...

Descripción completa

Detalles Bibliográficos
Autores principales: Zelniker, Thomas A., Ardissino, Maddalena, Andreotti, Felicita, O’Donoghue, Michelle L., Yin, Ophelia, Park, Jeong-Gun, Murphy, Sabina A., Ruff, Christian T., Lanz, Hans J., Antman, Elliott M., Braunwald, Eugene, Giugliano, Robert P., Merlini, Piera Angelica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884089/
https://www.ncbi.nlm.nih.gov/pubmed/33587659
http://dx.doi.org/10.1161/CIRCULATIONAHA.120.052216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884089/
https://www.ncbi.nlm.nih.gov/pubmed/33587659
http://dx.doi.org/10.1161/CIRCULATIONAHA.120.052216

Ejemplares similares